PTC Therapeutics Inc
NASDAQ:PTCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
US |
|
M
|
McDonald's Corp
SGO:MCD
|
US |
|
Chromadex Corp
NASDAQ:CDXC
|
US |
|
Nestle SA
F:NESR
|
CH |
|
Etteplan Oyj
LSE:0EDL
|
FI |
Wall Street
Price Targets
PTCT Price Targets Summary
PTC Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
PTCT
is 88.81 USD
with a low forecast of 60.6 USD and a high forecast of 130.2 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PTCT's stock price target?
Price Target
88.81
USD
According to Wall Street analysts, the average 1-year price target for
PTCT
is 88.81 USD
with a low forecast of 60.6 USD and a high forecast of 130.2 USD.
What is PTC Therapeutics Inc's Revenue forecast?
Projected CAGR
-4%
For the last 13 years the
compound annual growth rate for
PTC Therapeutics Inc's revenue is
35%.
The projected
CAGR
for the next 3 years is
-4%.
What is PTC Therapeutics Inc's Operating Income forecast?
Projected CAGR
-20%
The
compound annual growth rate
of PTC Therapeutics Inc's operating income for the next 3 years is
-20%.
What is PTC Therapeutics Inc's Net Income forecast?
Projected CAGR
-19%
For the last 13 years the
compound annual growth rate for
PTC Therapeutics Inc's net income is
70%.
The projected
CAGR
for the next 3 years is
-19%.
